| Comments |
The antibody specifically binds to an extrcellular domain of human vascular endothelial growth factor (VEGF) receptor 1 [fms-like tyrosine kinase (Flt-1) [U.S. Pat. 6,365,157; U.S. PAT. 6,448,077].
The 6.12 cell line was deposited at the ATCC as PTA-3344. Progeny from PTA-3344 are available as CRL-13006. |
| References |
Rockwell P, Goldstein NI. Monoclonal antibodies specific to VEGF receptors and uses thereof. US Patent 6,365,157 dated Apr 2 2002
Rockwell P, Goldstein NI. Chimeric and humanized monoclonal antibodies specific to VEGF receptors. US Patent 6,448,077 dated Sep 10 2002
Hay, R. J., Caputo, J. L., and Macy, M. L., Eds. (1992), ATCC Quality Control Methods for Cell Lines. 2nd edition, Published by ATCC.
Caputo, J. L., Biosafety procedures in cell culture. J. Tissue Culture Methods 11:223-227, 1988.
Fleming, D.O., Richardson, J. H., Tulis, J.J. and Vesley, D., (1995) Laboratory Safety: Principles and Practice. Second edition, ASM press, Washington, DC.
Biosafety in Microbiological and Biomedical Laboratories, 5th ed. HHS. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Washington DC: U.S. Government Printing Office; 2007. The entire text is available online.
|
